Off Patent
March 2026

Coreg CR

carvedilol phosphate

Waylis Therapeutics LLC

Capsule, extended release (oral) · NDA 022012

Last listed protection ended
March 11, 2026

The FDA listed 1 patent for Coreg CR, and this is the day the last one ended. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Ended
    Patent 8,101,209
    Claims the drug product
  2. Ended
    Patent 8,101,209
    Pediatric extension: six more months